INTRODUCTION: To evaluate the possibility that switching from reference biologic medicines to biosimilars could lead to altered clinical outcomes, including enhanced immunogenicity, compromised safety, or diminished efficacy for patients, a systematic literature review was conducted of all switching...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!